UPC_CFI_808/2025

DETECTION AND TREATMENT OF DISEASE EXHIBITING DISEASE CELL HETEROGENEITY AND SYSTEMS AND METHODS FOR COMMUNICATING TEST RESULTS

Einstweilige MaßnahmenEinstweilige MaßnahmenParis LDProvisional measuresOral Phase

2026-01-23PI abgelehntpi_motionApplication for provisional measures
The Paris Local Division rejected Guardant Health's application for provisional measures under three patents (EP 3 591 073, EP 3 443 066, EP 3 766 986) against Sophia Genetics. The court found issues of added matter in the divisional patent and insufficient evidence to demonstrate infringement with the required degree of certainty. Guardant Health's request regarding a fourth patent (EP 3 470 533) was withdrawn during proceedings. Guardant Health ordered to pay Sophia Genetics EUR 400,000 as interim costs.
2025-10-01Nur prozessualproceduralApplication for provisional measures
The Paris Local Division issued a scheduling order for the oral hearing in Guardant Health's preliminary injunction application against Sophia Genetics entities based on four patents (EP 3 766 986, EP 3 470 533, EP 3 443 066, EP 3 591 073) relating to genomic analysis, after defendants failed to appoint representatives within 15 days of service.